The Boehringer Ingelheim group of companies is one of the world’s 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, the privately–owned company currently has nearly 41,300 employees and 138 affiliated companies spread around the globe.

Boehringer Ingelheim is research-driven and dedicated to the discovery, development, manufacture and marketing of innovative human and animal health care products.

In 2008, Boehringer Ingelheim posted net sales of U.S. $17.0 billion (11.6 billion euro) while spending nearly one fifth of net sales on research and development in its largest business segment, Prescription Medicines.

Boehringer Ingelheim Corporation, based in Ridgefield, CT, is the U.S. headquarters to seven subsidiaries, and a member of the Boehringer Ingelheim worldwide group of companies. The U.S. Boehringer Ingelheim subsidiaries employ nearly 9,000 people.